Cystic Fibrosis

Cystic Fibrosis News

  • Vertex Reports Positive Results for Cystic Fibrosis Triple Combos Vertex Pharmaceuticals Inc on Tuesday said three different triple combinations of cystic fibrosis treatments significantly improved patient lung function in clinical trials, bolstering its goal of a therapy that could help up to 90 percent of patients with the life-shortening lung disease.
  • Lumacaftor/Ivacaftor Show Some Benefit for Children With Cystic Fibrosis Lumacaftor and ivacaftor improve lung function in young patients with cystic fibrosis (CF), according to one of the first trials to use lung clearance index (LCI) as a primary endpoint.
 

Cystic Fibrosis Perspective